Clinical Trials Logo

Metabolic Disease clinical trials

View clinical trials related to Metabolic Disease.

Filter by:

NCT ID: NCT03863431 Recruiting - Type 2 Diabetes Clinical Trials

The Influence of Overfeeding Different Macronutrients on Whole-body Insulin Sensitivity

Start date: May 22, 2019
Phase: N/A
Study type: Interventional

This study will investigate the effect of high-carbohydrate vs. high-fat overfeeding (130% of energy requirements) on whole body insulin sensitivity. Following habitual diet, participants will be randomly allocated to either a high-carbohydrate or a high-fat diet intervention for 14-days. On days 0, 7 and 14 participants will undergo anthropometric and metabolic testing (primarily an oral glucose tolerance test [OGTT]).

NCT ID: NCT03859934 Completed - Clinical trials for Type 2 Diabetes Mellitus

Metabolic Effects of Melatonin Treatment

Start date: September 26, 2019
Phase: Phase 1
Study type: Interventional

Modern living is associated with an epidemic of type 2 diabetes mellitus (T2DM). Sleep disturbances such as insomnia or frequent awakenings are strong risk factors for T2DM with several studies indicating a central role of melatonin. Additionally, a certain single nucleotide polymorphism in the melatonin receptor gene, MTNR1B rs10830963, with an allele frequency of 30 %, is associated with increased fasting plasma glucose and T2DM. Due to treatment of, among other things, insomnia, the use of melatonin is increasing rapidly in Denmark with a 100-fold increase from 2007-2012 in children and adolescents. No previous studies have thoroughly assessed changes in glucose and fatty acid metabolism after 3 months of melatonin treatment in patients with T2DM.

NCT ID: NCT03856606 Completed - Clinical trials for Cardiovascular Diseases

The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia

Start date: February 20, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of interrupting prolong sedentary behavior with interval exercise on postprandial metabolism following a high fat glucose tolerance test.

NCT ID: NCT03803345 Completed - Metabolic Disease Clinical Trials

The Association of Maternal Night-Eating Pattern With Glucose Tolerance During Pregnancy

Start date: March 28, 2019
Phase:
Study type: Observational

This study aims to assess the associations of maternal food timing with glucose levels during pregnancy.

NCT ID: NCT03796000 Completed - Metabolic Disease Clinical Trials

Characterization of Human Intestinal Macrophages in Metabolic Disease

iMAC
Start date: May 14, 2018
Phase:
Study type: Observational

This is a prospective, observational study aiming at improving the understanding of the pathophysiology of metabolic disease. As inflammation has been recognized as a key characteristic of metabolic disease but its starting point is still unknown, the investigators' aim is to characterize intestinal macrophages from human gut biopsies taken in diagnostic endoscopies of the gastrointestinal tract or in bariatric surgeries for clinical reasons.

NCT ID: NCT03685916 Completed - Metabolic Disease Clinical Trials

Screening of Phytochemical Rich Ingredients as 'Functional Foods' to Improve Cardiometabolic Health

PRIFF
Start date: April 25, 2018
Phase: N/A
Study type: Interventional

To find out whether consumption of different kinds of plant based functional food ingredients, traditionally used in Asia, can improve post-meal response of indicators of heart and metabolic (cardiometabolic) function.

NCT ID: NCT03682640 Recruiting - Diabetes Mellitus Clinical Trials

Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes

AIDIT
Start date: September 2018
Phase: Phase 2
Study type: Interventional

Increasing evidences suggest that infections are important etiological factors for the development of Type 1 Diabetes (T1D). The overall hypothesis of the study is that the treatment of children, during the first year after diagnosis of T1D with Azithromycin, combined with repeated episodes of intensified insulin treatment to induce maximal beta-cell rest, and dietician support to promote dietary habits that minimize the likelihood of bacterial reflux from the duodenum to the pancreatic duct, will lead to preservation of beta cell function. This trial will examine whether the AIDIT protocol initiated within one week from diagnosis could preserve insulin production in children with Type 1 Diabetes.

NCT ID: NCT03675360 Completed - Diabetes Clinical Trials

Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial

ADEPT
Start date: September 25, 2018
Phase: N/A
Study type: Interventional

The proposed randomized controlled trial will test the effect of a low-carbohydrate diet on hemoglobin A1c among individuals with elevated hemoglobin A1c that are within the range of prediabetes or diabetes. Results may provide evidence about the role of carbohydrate restriction in individuals with or at high risk of type 2 diabetes.

NCT ID: NCT03610087 Completed - Clinical trials for Cardiovascular Risk Factor

Technology-Enabled Collaborative Care for Youth

TECC-Y
Start date: July 25, 2018
Phase: N/A
Study type: Interventional

The overall objective is to develop scalable interventions to address the physical health needs of patients affected by early psychosis. The objective of this project is to conduct a feasibility study of a high intensity technology-enabled collaborative care model (CCM) compared to lower intensity self-help modules and email support for early identification and treatment of cardio-metabolic risk factors in youth, ages 16-29, affected by early psychosis.

NCT ID: NCT03594812 Completed - Clinical trials for Cardiovascular Risk Factor

Effect of Aerobic Exercise Associated With Abdominal Radiofrequency on on Adipose Tissue in Women:

Start date: July 15, 2018
Phase: N/A
Study type: Interventional

The purpose of the present study was to evaluate the effects of one session of aerobic exercise associated with radiofrequency in lipolytic activity and lipid profile.